77
Participants
Start Date
May 31, 2002
Primary Completion Date
January 31, 2009
alvocidib
Given IV
irinotecan hydrochloride
Given IV
fluorouracil
Given IV
leucovorin calcium
Given IV
laboratory biomarker analysis
Correlative studies
Memorial Sloan Kettering Cancer Center, New York
National Cancer Institute (NCI)
NIH